{"denoms":[{"counts":[{"groupId":"BG000","value":"9"}],"units":"Participants"}],"groups":[{"description":"Intrapleural chemotherapy plus systemic chemotherapy:\n\nThoracoscopy to implant two intrapleural catheters followed by intrapleural chemotherapy with doxorubicin and cisplatin (weeks 1, 2, 4, 5, 7, and 8). Systemic chemotherapy treatments with cisplatin and pemetrexed during weeks 3, 6, and 9. Intrapleural radiotherapy with P-32 will be given 3 weeks after last dose of chemotherapy and 11 to 12 weeks after initial thoracoscopy.\n\nDoxorubicin: A medication used in cancer chemotherapy, derived by chemical semisynthesis from a bacterial species.\n\nCisplatin: Platinum-based antineoplastic\n\nPemetrexed: Folate Analog Metabolic Inhibitor\n\nRadiotherapy: Standard procedure given 3 weeks after last dose of chemotherapy","id":"BG000","title":"Multimodal Lung Sparing Regimen"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"18-65 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"> 65 years"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"Non-specific"}],"description":"Data were not collected.","paramType":"COUNT_OF_PARTICIPANTS","title":"Sex/Gender, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":"Caucasian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Hispanic"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}